These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1691375)
1. Effects of a novel renin inhibitor in patients with essential hypertension. Bursztyn M; Gavras I; Tifft CP; Luther R; Boger R; Gavras H J Cardiovasc Pharmacol; 1990 Mar; 15(3):493-500. PubMed ID: 1691375 [TBL] [Abstract][Full Text] [Related]
2. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients. Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973 [TBL] [Abstract][Full Text] [Related]
3. Assessment of renin dependency of hypertension with a dipeptide renin inhibitor. Weber MA; Neutel JM; Essinger I; Glassman HN; Boger RS; Luther R Circulation; 1990 Jun; 81(6):1768-74. PubMed ID: 2188754 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamics, pharmacokinetics and clinical effectiveness of captopril in patients with hypertension]. Kukes VG; Nasyrov ShN; Volchenok VI; Toporova EA; Abdunazarov TA Kardiologiia; 1990 Mar; 30(3):28-32. PubMed ID: 2199718 [TBL] [Abstract][Full Text] [Related]
5. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
6. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity. Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905 [TBL] [Abstract][Full Text] [Related]
7. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man. Bursztyn M; Gavras I; Tifft CP; Bauer JH; Melby JC; Gavras H J Hypertens Suppl; 1989 Dec; 7(6):S306-7. PubMed ID: 2698944 [TBL] [Abstract][Full Text] [Related]
8. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
9. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat. Neutel JM; Luther RR; Boger RS; Weber MA Am Heart J; 1991 Oct; 122(4 Pt 1):1094-100. PubMed ID: 1656720 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension. Azizi M; Guyene TT; Chatellier G; Ménard J J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166 [TBL] [Abstract][Full Text] [Related]
12. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension. Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387 [TBL] [Abstract][Full Text] [Related]
13. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients. Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709 [TBL] [Abstract][Full Text] [Related]
14. Effects of renin inhibition in systemic hypertension. Anderson PW; Do YS; Schambelan M; Horton R; Boger RS; Luther RR; Hsueh WA Am J Cardiol; 1990 Dec; 66(19):1342-7. PubMed ID: 2244565 [TBL] [Abstract][Full Text] [Related]
15. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations. Palmer RK; Rapundalo ST; Batley BL; Barnes AE; Singh S; Ryan MJ; Taylor DG Clin Exp Hypertens; 1993 Jul; 15(4):663-81. PubMed ID: 8374609 [TBL] [Abstract][Full Text] [Related]
16. Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527 [TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril. Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Matsuura H; Shingu T; Kajiyama G Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858 [TBL] [Abstract][Full Text] [Related]
18. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)]. Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876 [TBL] [Abstract][Full Text] [Related]
19. Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively. Stanton AV; Dicker P; O'Brien ET Am J Hypertens; 2009 Sep; 22(9):954-7. PubMed ID: 19556972 [TBL] [Abstract][Full Text] [Related]
20. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH; Reams GP; Wu Z; Lau-Sieckman A J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]